146 related articles for article (PubMed ID: 23946154)
1. Synthesis and crystal structure of anhydrous analog of 1,25-dihydroxyvitamin d3.
Pietraszek A; Malińska M; Chodyński M; Martynow J; Krupa M; Maruszak W; Woźniak K; Kutner A
J Pharm Sci; 2013 Nov; 102(11):3925-31. PubMed ID: 23946154
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective synthesis of 1β,25-Dihydroxyvitamin D
Loureiro J; Maestro MA; Mouriño A; Sigüeiro R
J Steroid Biochem Mol Biol; 2016 Nov; 164():56-58. PubMed ID: 26363188
[TBL] [Abstract][Full Text] [Related]
3. A novel and practical route to A-ring enyne synthon for 1 alpha,25-dihydroxyvitamin D3 analogs: synthesis of A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D2 and 3-methyl-1,25-dihydroxyvitamin D3.
Konno K; Maki S; Fujishima T; Liu Z; Miura D; Chokki M; Takayama H
Bioorg Med Chem Lett; 1998 Jan; 8(2):151-6. PubMed ID: 9871644
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification.
Tocchini-Valentini G; Rochel N; Wurtz JM; Moras D
J Med Chem; 2004 Apr; 47(8):1956-61. PubMed ID: 15055995
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative, low-calcemic, fluorinated sulfone analogs of 1alpha,25-dihydroxyvitamin D3: chemical synthesis and biological evaluation.
Usera AR; Dolan PM; Kensler TW; Posner GH
Bioorg Med Chem; 2007 Aug; 15(16):5509-18. PubMed ID: 17560112
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activities of vitamin D3 derivatives with cyanoalkyl side chain at C-2 position.
Saitoh H; Watanabe H; Kakuda S; Takimoto-Kamimura M; Takagi K; Takeuchi A; Takenouchi K
J Steroid Biochem Mol Biol; 2015 Apr; 148():27-30. PubMed ID: 25500068
[TBL] [Abstract][Full Text] [Related]
7. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
Shimizu M; Miyamoto Y; Takaku H; Matsuo M; Nakabayashi M; Masuno H; Udagawa N; DeLuca HF; Ikura T; Ito N
Bioorg Med Chem; 2008 Jul; 16(14):6949-64. PubMed ID: 18539034
[TBL] [Abstract][Full Text] [Related]
8. Structural Properties, Order-Disorder Phenomena, and Phase Stability of Orotic Acid Crystal Forms.
Braun DE; Nartowski KP; Khimyak YZ; Morris KR; Byrn SR; Griesser UJ
Mol Pharm; 2016 Mar; 13(3):1012-29. PubMed ID: 26741914
[TBL] [Abstract][Full Text] [Related]
9. Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis.
Nakano Y; Kato Y; Imai K; Ochiai E; Namekawa J; Ishizuka S; Takenouchi K; Tanatani A; Hashimoto Y; Nagasawa K
J Med Chem; 2006 Apr; 49(8):2398-406. PubMed ID: 16610783
[TBL] [Abstract][Full Text] [Related]
10. 13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.
Plonska-Ocypa K; Sicinski RR; Plum LA; Grzywacz P; Frelek J; Clagett-Dame M; DeLuca HF
Bioorg Med Chem; 2009 Feb; 17(4):1747-63. PubMed ID: 19167893
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and preliminary biological evaluation of 20-epi-eldecalcitol [20-epi-1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3: 20-epi-ED-71].
Hatakeyama S; Yoshino M; Eto K; Takahashi K; Ishihara J; Ono Y; Saito H; Kubodera N
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):25-8. PubMed ID: 20304058
[TBL] [Abstract][Full Text] [Related]
12. Effect of pulverization on hydration kinetic behaviors of creatine anhydrate powders.
Sakata Y; Shiraishi S; Otsuka M
Colloids Surf B Biointerfaces; 2004 Dec; 39(4):187-93. PubMed ID: 15555902
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of an anhydrous form of trehalose: structure of water channels of trehalose polymorphism.
Nagase H; Ogawa N; Endo T; Shiro M; Ueda H; Sakurai M
J Phys Chem B; 2008 Jul; 112(30):9105-11. PubMed ID: 18605683
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D analogs as therapeutic agents: a clinical study update.
Wu-Wong JR; Tian J; Goltzman D
Curr Opin Investig Drugs; 2004 Mar; 5(3):320-6. PubMed ID: 15083599
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of 20-hydroxyvitamin D
Fujishima T; Suenaga T; Kawahata M; Yamaguchi K
J Steroid Biochem Mol Biol; 2019 Mar; 187():27-33. PubMed ID: 30389627
[TBL] [Abstract][Full Text] [Related]
16. Methyl substitution of the 25-hydroxy group on 2-methylene-19-nor-1alpha,25-dihydroxyvitamin D3 (2MD) reduces potency but allows bone selectivity.
Grzywacz P; Plum LA; Sicinski RR; Clagett-Dame M; DeLuca HF
Arch Biochem Biophys; 2007 Apr; 460(2):274-84. PubMed ID: 17094936
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and metabolic studies of 1α,2α,25-, 1α,4α,25- and 1α,4β,25-trihydroxyvitamin D3.
Takano M; Sawada D; Yasuda K; Nishikawa M; Takeuchi A; Takagi K; Horie K; Reddy GS; Chen TC; Sakaki T; Kittaka A
J Steroid Biochem Mol Biol; 2015 Apr; 148():34-7. PubMed ID: 25263656
[TBL] [Abstract][Full Text] [Related]
18. A new approach to 19-nor-A-ring phosphine oxide for the convergent synthesis of 19-nor-calcitriol.
Sigüeiro R; Otero R; González-Berdullas P; Loureiro J; Mouriño A; Maestro MA
J Steroid Biochem Mol Biol; 2017 Oct; 173():86-88. PubMed ID: 27592138
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationship of p-carborane-based non-secosteroidal vitamin D analogs.
Fujii S; Kano A; Songkram C; Masuno H; Taoda Y; Kawachi E; Hirano T; Tanatani A; Kagechika H
Bioorg Med Chem; 2014 Feb; 22(4):1227-35. PubMed ID: 24486205
[TBL] [Abstract][Full Text] [Related]
20. Vibrational and thermal analyses of multicomponent crystal forms of the anti-HIV drugs lamivudine and zalcitabine.
Martins FT; Guimarães FF; Honorato SB; Ayala AP; Ellena J
J Pharm Biomed Anal; 2015 Jun; 110():76-82. PubMed ID: 25808817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
